Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,743 | 90 | 99.3% |
| Education | $11.56 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $395.57 | 23 | $0 (2022) |
| Paratek Pharmaceuticals, Inc. | $269.74 | 6 | $0 (2021) |
| Amarin Pharma Inc. | $170.98 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $122.84 | 8 | $0 (2023) |
| IBSA Pharma Inc. | $111.99 | 7 | $0 (2022) |
| Exact Sciences Corporation | $111.36 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $107.57 | 7 | $0 (2024) |
| ABBVIE INC. | $79.32 | 5 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $50.87 | 3 | $0 (2022) |
| Lilly USA, LLC | $50.87 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $151.93 | 7 | Janssen Pharmaceuticals, Inc ($49.35) |
| 2023 | $122.66 | 6 | Exact Sciences Corporation ($70.21) |
| 2022 | $327.46 | 20 | IBSA Pharma Inc. ($52.94) |
| 2021 | $907.26 | 48 | Novo Nordisk Inc ($334.08) |
| 2020 | $200.95 | 7 | Paratek Pharmaceuticals, Inc. ($126.04) |
| 2019 | $15.64 | 1 | Amgen Inc. ($15.64) |
| 2018 | $28.53 | 2 | Novo Nordisk Inc ($14.53) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Oncology | ||||||
| 09/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Neuroscience | ||||||
| 05/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Oncology | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Obesity | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Oncology | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Oncology | ||||||
| 07/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: Endocrinology | ||||||
| 08/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 07/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.52 | General |
| 05/23/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/05/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Cardiovascular | ||||||
| 04/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: RESPIRATORY | ||||||
| 03/25/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiovascular | ||||||
| 03/23/2022 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 437 | 555 | $107,962 | $26,774 |
| 2022 | 12 | 403 | 498 | $105,975 | $27,869 |
| 2021 | 12 | 422 | 512 | $108,656 | $29,020 |
| 2020 | 12 | 467 | 537 | $102,491 | $30,274 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 141 | $46,663 | $11,285 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 87 | $19,852 | $5,568 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $9,841 | $3,569 | 36.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 17 | 18 | $10,269 | $2,376 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,511 | $1,137 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $6,554 | $1,058 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 93 | $837.00 | $781.20 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 54 | 55 | $4,785 | $418.55 | 8.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 38 | $2,982 | $365.76 | 12.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 64 | $668.16 | $215.40 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 142 | $46,993 | $12,130 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 71 | $16,201 | $4,543 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $11,950 | $4,502 | 37.7% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 14 | 14 | $7,987 | $1,957 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $6,226 | $1,570 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,512 | $1,453 | 22.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 20 | 21 | $5,250 | $735.55 | 14.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 30 | 31 | $1,922 | $254.64 | 13.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 65 | 83 | $747.00 | $245.55 | 32.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 12 | 12 | $661.68 | $229.59 | 34.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 39 | 46 | $480.24 | $157.68 | 32.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 12 | 12 | $1,044 | $91.32 | 8.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 131 | $43,353 | $12,159 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 54 | $12,322 | $3,630 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $8,084 | $3,061 | 37.9% |
About Dr. Henry Moon, MD
Dr. Henry Moon, MD is a Family Medicine healthcare provider based in Dacula, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780646083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Moon, MD has received a total of $1,754 in payments from pharmaceutical and medical device companies, with $151.93 received in 2024. These payments were reported across 91 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,743).
As a Medicare-enrolled provider, Moon has provided services to 1,729 Medicare beneficiaries, totaling 2,102 services with total Medicare billing of $113,938. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dacula, GA
- Active Since 04/04/2006
- Last Updated 01/15/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780646083
Products in Payments
- NUZYRA (Drug) $269.74
- Ozempic (Drug) $268.17
- Vascepa (Drug) $170.98
- TRELEGY ELLIPTA (Drug) $122.84
- Tirosint (Drug) $111.99
- Cologuard Collection Kit (Device) $111.36
- Livalo (Drug) $50.87
- RYBELSUS (Drug) $50.73
- SPRAVATO (Drug) $49.35
- FARXIGA (Drug) $44.18
- TRULICITY (Drug) $35.95
- VRAYLAR (Drug) $33.80
- UBRELVY (Drug) $33.78
- LEQVIO (Drug) $32.85
- BREZTRI (Drug) $27.42
- AIRSUPRA (Drug) $24.41
- Dexcom G6 Transmitter (Medical Supply) $23.24
- Yupelri (Drug) $19.35
- ZENPEP (Drug) $17.47
- PENNSAID (Drug) $17.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dacula
Dr. Inchol Yun
Family Medicine — Payments: $15,022
Sumathi Puttu, Md, MD
Family Medicine — Payments: $10,611
Dr. Carla Price, M.d, M.D
Family Medicine — Payments: $4,635
Rene Latoni, Md, MD
Family Medicine — Payments: $2,065
David Najjar, M.d, M.D
Family Medicine — Payments: $1,859
Jody Bahnmiller-Brasil, M.d, M.D
Family Medicine — Payments: $1,691